This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Partial fee reimbursement granted in Tandem-Roche UPC patent case after settlement

( July 3, 2025, 08:14 GMT | Official Statement) -- MLex Summary: Tandem Diabetes Care has appealed a decision that upheld Roche’s EP 2,196,231, relating to a system for ambulatory drug infusion. The parties later settled the case before the written procedure concluded, and Tandem then requested a partial refund of appeal fees. The Court of Appeal of the Unified Patent Court confirmed the settlement, and ruled that Tandem is entitled to a 60 percent reimbursement of court fees.The order is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections